Plunkett Research Online: AVEO Pharmaceuticals Inc

AVEO PHARMACEUTICALS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth .....


AVEO PHARMACEUTICALS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 857-400-0101
Fax:
Address: 30 Winter Street
Boston, MA 02108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: LG Corporation

Contacts Description

Michael BaileyCEO/Director/President
Erick LuceraCFO/Chief Accounting Officer
See More
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States. FOTIVDA is an oral, next-generation vascular endothelial growth .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture